Natural Compounds Isolated from Stachybotrys chartarum Are Potent Inhibitors of Human Protein Kinase CK2.
Samer HaidarFranziska M JürgensDagmar AicheleAnnika JagelsHans-Ulrich HumpfJoachim JosePublished in: Molecules (Basel, Switzerland) (2021)
A large number of secondary metabolites have been isolated from the filamentous fungus Stachybotrys chartarum and have been described before. Fourteen of these natural compounds were evaluated in vitro in the present study for their inhibitory activity towards the cancer target CK2. Among these compounds, stachybotrychromene C, stachybotrydial acetate and acetoxystachybotrydial acetate turned out to be potent inhibitors with IC50 values of 0.32 µM, 0.69 µM and 1.86 µM, respectively. The effects of these three compounds on cell proliferation, growth and viability of MCF7 cells, representing human breast adenocarcinoma as well as A427 (human lung carcinoma) and A431 (human epidermoid carcinoma) cells, were tested using EdU assay, IncuCyte® live-cell imaging and MTT assay. The most active compound in inhibiting MCF7 cell proliferation was acetoxystachybotrydial acetate with an EC50 value of 0.39 µM. In addition, acetoxystachybotrydial acetate turned out to inhibit the growth of all three cell lines completely at a concentration of 1 µM. In contrast, cell viability was impaired only moderately, to 37%, 14% and 23% in MCF7, A427 and A431 cells, respectively.
Keyphrases
- endothelial cells
- cell proliferation
- protein kinase
- induced apoptosis
- induced pluripotent stem cells
- breast cancer cells
- cell cycle arrest
- pluripotent stem cells
- signaling pathway
- high throughput
- pi k akt
- high resolution
- magnetic resonance imaging
- cell death
- young adults
- anti inflammatory
- photodynamic therapy
- rectal cancer
- locally advanced
- single cell